← Back to Search

Dialectical Behavior Therapy for Borderline Personality Disorder (DBT-RU Trial)

N/A

Waitlist Available

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 years or older

Agreement to discontinue other forms of therapy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up past six months

Awards & highlights

DBT-RU Trial Summary

This trial establishes a psychological treatment clinic within the GSAPP to research and improve existing treatments for complex problems, develop new and more effective treatments, and understand severe psychopathology.

Who is the study for?

This trial is for adults over 18 with Borderline Personality Disorder (BPD) who live close to the clinic and can commute. Participants must agree to be recorded during sessions, pay for services, volunteer for research assessments, and stop any other therapies they're receiving.Check my eligibility

What is being tested?

The study tests Dialectical Behavior Therapy (DBT) at Rutgers University's clinic. It aims to improve therapist training, develop better treatments, understand severe psychopathology, and evaluate treatment outcomes including factors influencing change.See study design

What are the potential side effects?

Since DBT is a type of psychotherapy involving talk therapy and skill development rather than medication or medical procedures, it typically does not have physical side effects but may sometimes cause emotional discomfort.

DBT-RU Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I agree to stop other treatments.

DBT-RU Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ past six months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~past six months

This trial's timeline: 3 weeks for screening, Varies for treatment, and past six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Self-Injurious Thoughts and Behaviors Interview

Structured Clinical Interview for DSM-5

Secondary outcome measures

Borderline Symptom List (BSL-23)

Brief Symptom Inventory (BSI)

Difficulties in Emotion Regulation Scale

Side effects data

From 2012 Phase 4 trial • 91 Patients • NCT00533117

10%

Hospitalization or ED visitn

100%

80%

60%

40%

20%

Study treatment Arm

Supportive Therapy With Fluoxetine

Dialectical Behavior Therapy With Placebo

Supportive Therapy With Placebo

Dialectical Behavior Therapy With Fluoxetine

DBT-RU Trial Design

1Treatment groups

Experimental Treatment

Group I: Dialectical Behavior TherapyExperimental Treatment1 Intervention

All participants receive six months of standard DBT which includes individual therapy, skills training, and as-needed phone consultation.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Dialectical Behavior Therapy

2016

Completed Phase 4

~820

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

64,132 Total Patients Enrolled

1 Trials studying Borderline Personality Disorder

100 Patients Enrolled for Borderline Personality Disorder

Media Library

Dialectical Behavior Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03123198 — N/A

Borderline Personality Disorder Research Study Groups: Dialectical Behavior Therapy

Borderline Personality Disorder Clinical Trial 2023: Dialectical Behavior Therapy Highlights & Side Effects. Trial Name: NCT03123198 — N/A

Dialectical Behavior Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03123198 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the recruitment quota for this experiment?

"Affirmative. The information available on clinicaltrials.gov reveals enrolment is still in progress for this medical trial, which was initially posted on the 1st of March 2010 and updated most recently on the 15th of November 2022. 100 patients are being sought from a single location to participate in the experiment."

Answered by AI

Are there still opportunities to enroll in this clinical research?

"Per clinicaltrials.gov, this medical trial is enrolling patients and has been modified most recently on November 15th 2022; it was initially posted on March 1st 2010."

Answered by AI

Who else is applying?

What state do they live in?

New York

Louisiana

New Jersey

How old are they?

< 18

18 - 65

What site did they apply to?

Rutgers University

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

I am almost 60 years old, and Ive never had the time or the financial wherewithal to receive mental health treatment. I also have PTSD, which may impact how I should be treated. Im hoping for another 10-15 years, and Id like to live them out in the best mental state possible.

PatientReceived 1 prior treatment